We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 21% below its sector, cheaper than its peers on earnings.
Empreendimentos Pague Menos S.A. operates a prominent pharmacy chain across Brazil, offering a comprehensive array of health and wellness products. Their extensive inventory includes a wide variety of medications spanning numerous therapeutic categories such as pain relief, allergy treatment, digestive health, diabetes management, and vitamins. Beyond pharmaceuticals, the company provides a vast selection of personal care and beauty products, dermo-cosmetics, and specialized items for mothers and babies. They also stock general merchandise, including toys, clothing, food, beverages, and various household essentials. Established in 1981 and headquartered in Fortaleza, Brazil, Pague Menos manages a substantial retail network of 1,105 stores throughout the country.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save PGMN3.SA and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
